Brace Pharma Capital is a strategic investment firm focused on innovative, life-changing therapies for diseases with high unmet medical needs. Formed by EMS S/A, the largest pharmaceutical company in Brazil, and high net worth biotech investors, they provide strategic guidance, industry connections, and operational support to their portfolio companies.
| Fund Size | N/A USD |
| Stages Focus | Pre-Seed, Seed, Series A |
| Sectors Focus | Biotech, Pharmaceutical |
| Portfolio Size | 11 companies |
Brace Pharma Capital's investment thesis is centered on supporting early-stage biotech and pharmaceutical companies that are developing innovative therapies and technologies aimed at addressing significant unmet medical needs.
Target Founders: Entrepreneurs with a robust vision for groundbreaking therapies
Sectors: Primarily biotech and pharmaceutical
Stage: Early-stage investments, typically seed to Series A
Check Size: Varies, usually within the seed to Series A funding range
Geography: Global focus, targeting high-impact therapies
Deal Criteria: Emphasis on innovative therapies with significant unmet medical needs
Check more details: https://www.bracepharma.com/investment-criteria/
Active team contains 4 members (0 partners, 0 founders).
Brace Pharma Capital is a strategic investment firm focused on innovative, life-changing therapies for diseases with high unmet medical needs, formed by EMS S/A and high net worth biotech investors.
The firm invests in early-stage biotech and pharmaceutical companies, providing both financial and strategic support to help these companies develop groundbreaking therapies.
Investor Profile: Brace Pharma Capital on EzFunding
Brace Pharma Capital focuses on supporting early-stage biotech and pharmaceutical companies that are developing innovative therapies and technologies aimed at addressing significant unmet medical needs.
They target founders with a robust vision for groundbreaking therapies and invest primarily in the biotech and pharmaceutical sectors.
Investor Profile: Brace Pharma Capital on EzFunding
Brace Pharma Capital invests in the pre-seed, seed, and Series A stages.
They provide financial and strategic support to help early-stage companies develop and bring innovative therapies to market.
Investor Profile: Brace Pharma Capital on EzFunding
Brace Pharma Capital primarily invests in the biotech and pharmaceutical sectors.
They focus on companies developing innovative therapies and technologies aimed at addressing significant unmet medical needs.
Investor Profile: Brace Pharma Capital on EzFunding
The typical check size for Brace Pharma Capital ranges from $50,000 to $1,000,000 USD.
This range allows them to support a variety of early-stage companies in the biotech and pharmaceutical sectors.
Investor Profile: Brace Pharma Capital on EzFunding
No, Brace Pharma Capital does not accept cold outreach.
They prefer to engage with founders through strategic partnerships and existing networks rather than unsolicited proposals.
Investor Profile: Brace Pharma Capital on EzFunding
The key team members at Brace Pharma Capital include Daniel E. Salazar, Ph.D., Todd Brady, Carlos Sanchez, Raymond F. Schinazi, Ph.D., D.Sc.
These individuals bring extensive experience and expertise in the biotech and pharmaceutical industries to the firm.
Investor Profile: Brace Pharma Capital on EzFunding
Brace Pharma Capital was formed by EMS S/A and high net worth biotech investors to focus on innovative, life-changing therapies for diseases with high unmet medical needs.
The firm has a strong commitment to supporting early-stage biotech and pharmaceutical companies in their mission to develop groundbreaking therapies.
Investor Profile: Brace Pharma Capital on EzFunding
Brace Pharma Capital's investment focus in the biotech sector is on early-stage companies developing innovative therapies and technologies aimed at addressing significant unmet medical needs.
They support founders with a robust vision for groundbreaking therapies in this sector.
Investor Profile: Brace Pharma Capital on EzFunding
Brace Pharma Capital's investment focus in the pharmaceutical sector is on early-stage companies developing innovative therapies and technologies aimed at addressing significant unmet medical needs.
They support founders with a robust vision for groundbreaking therapies in this sector.
Investor Profile: Brace Pharma Capital on EzFunding